SCHEMBL8419030

SCHEMBL8419030

CCCCCCCCCCCCC(C(=O)O)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.40
LMNA P02545 1/20 0.40
RECQL P46063 1/20 0.40
FFAR1 O14842 1/20 0.40
NR5A2 O00482 1/20 0.39
NR5A1 Q13285 1/20 0.39
MAPT P10636 1/20 0.39
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39
GLRA3 O75311 1/20 0.39
GLRB P48167 1/20 0.39
F2R P25116 1/20 0.39
KCNH2 Q12809 2/20 0.39
HSPD1 P10809 1/20 0.38
BLM P54132 1/20 0.38
HSPE1 P61604 1/20 0.38
GAA P10253 3/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39475 1.00 GPR84 (0.40) GPR84LMNARECQLFFAR1NR5A2
SCHEMBL2542322 1.00 GPR84 (0.40) GPR84LMNARECQLFFAR1NR5A2
SCHEMBL11739834 1.00 GPR84 (0.40) GPR84LMNARECQLFFAR1NR5A2
SCHEMBL11728968 1.00 GPR84 (0.40) GPR84LMNARECQLFFAR1NR5A2
SCHEMBL11644932 0.90 PPARG (0.40) MAPTF2RKCNH2BLMGAA
SCHEMBL6659436 0.89 LMNA (0.40) LMNARECQLFFAR1NR5A2NR5A1
SCHEMBL1278397 0.88 LMNA (0.44) LMNARECQLMAPTGLRA3GLRB
SCHEMBL11614489 0.87 LMNA (0.39) LMNARECQLNR5A2NR5A1F2R
SCHEMBL206895 0.87 GMNN (0.37) LMNARECQLNR5A2NR5A1MAPT
SCHEMBL206012 0.87 GMNN (0.37) LMNARECQLNR5A2NR5A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990173-A ANTICHOLESTEROL AGENTS; TREATING ATHEROSCLEROSIS; ENZYME INHIBITORS OF ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE (ACAT) PIERRE FABRE MEDICAMENT (FR) 1999-11-23 US disclosed